Across TCGA pan-cancer cohorts, FAAP100 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated FAAP100 data layer compared with 25 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher FAAP100 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAAP100 expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.

PDAC, LUAD, and UCEC are the cancer types where FAAP100 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	II,III,IV	0.293	0.658	.008	40	view →
LUAD	OS	Tertile	All	0.560	1.000	.009	11	view →
UCEC	DFS	Median	III,IV	0.900	0.499	.025	4	view →
GBM	DFS	Tertile	All	0.501	0.274	.038	2	view →
CCRCC	DFS	Median	All	0.840	1.000	.011	2	view →
LSCC	OS	Median	All	0.773	1.000	.029	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

Exploration

Same gene, other analysis: FAAP100 tumor-vs-normal RNA expression · all FAAP100 data types